Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review
S Galmiche, LBL Nguyen, E Tartour… - Clinical Microbiology …, 2022 - Elsevier
Background Available data show that COVID-19 vaccines may be less effective in
immunocompromised populations, who are at increased risk of severe COVID-19 …
immunocompromised populations, who are at increased risk of severe COVID-19 …
Immunogenicity and risk factors associated with poor humoral immune response of SARS-CoV-2 vaccines in recipients of solid organ transplant: a systematic review …
K Manothummetha, N Chuleerarux… - JAMA network …, 2022 - jamanetwork.com
Importance Recipients of solid organ transplant (SOT) experience decreased
immunogenicity after COVID-19 vaccination. Objective To summarize current evidence on …
immunogenicity after COVID-19 vaccination. Objective To summarize current evidence on …
[HTML][HTML] Cellular immunity predominates over humoral immunity after homologous and heterologous mRNA and vector-based COVID-19 vaccine regimens in solid …
T Schmidt, V Klemis, D Schub, S Schneitler… - American Journal of …, 2021 - Elsevier
Knowledge on the immunogenicity of vector-based and mRNA-vaccines in solid organ
transplant recipients is limited. Therefore, SARS-CoV-2–specific T cells and antibodies were …
transplant recipients is limited. Therefore, SARS-CoV-2–specific T cells and antibodies were …
[HTML][HTML] The global impact of COVID-19 on solid organ transplantation: two years into a pandemic
A Nimmo, D Gardiner, I Ushiro-Lumb, R Ravanan… - …, 2022 - journals.lww.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic has had a major global
impact on solid organ transplantation (SOT). An estimated 16% global reduction in …
impact on solid organ transplantation (SOT). An estimated 16% global reduction in …
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper
T Marjot, CS Eberhardt, T Boettler, LS Belli… - Journal of …, 2022 - Elsevier
The COVID-19 pandemic has presented a serious challenge to the hepatology community,
particularly healthcare professionals and patients. While the rapid development of safe and …
particularly healthcare professionals and patients. While the rapid development of safe and …
[HTML][HTML] Immunogenicity of COVID-19 vaccines in solid organ transplant recipients: a systematic review and meta-analysis
X Chen, D Luo, B Mei, J Du, X Liu, H Xie, L Liu… - Clinical Microbiology …, 2023 - Elsevier
Background Solid organ transplant (SOT) recipients are at increased risks of morbidity and
mortality associated with COVID-19. Objectives This study aimed to evaluate the …
mortality associated with COVID-19. Objectives This study aimed to evaluate the …
Humoral and cellular vaccination responses against SARS-CoV-2 in hematopoietic stem cell transplant recipients
M Lindemann, V Klisanin, L Thümmler, N Fisenkci… - Vaccines, 2021 - mdpi.com
The cellular response to SARS-CoV-2 vaccination and infection in allogeneic hematopoietic
stem cell transplant (HSCT) recipients is not yet clear. In the current study, HSCT recipients …
stem cell transplant (HSCT) recipients is not yet clear. In the current study, HSCT recipients …
[HTML][HTML] COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis
Methods We collected data via three databases from inception to February 16, 2022, and
reported pooled seroconversion rate, T cell response and safety data after two vaccine …
reported pooled seroconversion rate, T cell response and safety data after two vaccine …
[HTML][HTML] Negative immune responses to two-dose mRNA COVID-19 vaccines in renal allograft recipients assessed with simple antibody and interferon gamma release …
M Crespo, A Barrilado-Jackson, E Padilla… - American Journal of …, 2022 - Elsevier
Studies are urgently needed to characterize immunogenicity, efficacy, and safety of severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccines in kidney …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccines in kidney …